Cirata PLC
24 July 2026
THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER TO BUY, ACQUIRE OR SUBSCRIBE FOR (OR THE SOLICITATION OF AN OFFER TO BUY, ACQUIRE OR SUBSCRIBE FOR) SECURITIES IN ANY JURISDICTION.
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ('MAR'). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ('RIS'), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
24 July 2026
Cirata plc
("Cirata" or the "Company")
Result of General Meeting and Total Voting Rights
Cirata plc (LSE: CRTA), the data orchestration technology company, announces that all resolutions set out in the circular dated 29 June 2026 and put to shareholders at the General Meeting held earlier today were duly passed. Further to the Launch Announcement, the additional condition of the establishment of a UK branch by the Company for those investors who require that the Placing Shares qualify for relief under Part 6 of the Income Tax Act 2007 or exemption or relief available under sections 151A of Taxation of Chargeable Gains Act 1992 has been satisfied, and accordingly all New Ordinary Shares will be issued at Admission.
Accordingly, the Company now has the requisite authority to issue 36,310,971 New Ordinary Shares at a price of 15 pence per share, raising total gross proceeds of approximately £5.4m (c.$7.2m) via the Fundraising.
Application has been made for a total of 36,310,971 New Ordinary Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be issued and admitted to trading on AIM. Admission and dealings are expected to commence at or around 8.00 a.m. on 28 July 2026.
Following Admission, the Company's issued share capital will comprise 162,759,626 ordinary shares of 10p each, with voting rights. This figure may be used by shareholders as the denominator for calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalized terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the Circular posted to shareholders on 29 June 2026.
For further information, please contact:
|
Cirata |
+1 (925) 380 1728 |
|
Stephen Kelly, Chief Executive Officer |
|
|
Ed Kee, Finance Director |
|
|
Daniel Hayes, Investor Relations |
|
|
FTI Consulting |
+44 (0)20 3727 1137 |
|
Matt Dixon / Kwaku Aning |
|
|
Stifel (Nomad and Joint Broker) |
+44 (0)20 7710 7600 |
|
Fred Walsh / Brough Ransom / Ben Good / Daniel Dearden-Williams |
|
|
Panmure Liberum (Joint Broker) |
+44 (0)20 3100 2000 |
|
James Sinclair-Ford / Rupert Dearden / Piers Shimwell |
About Cirata
Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated.
For more information about Cirata, visit www.cirata.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.